Detailed view for TcCLB.506563.70

Basic information

TDR Targets ID: 31978
Trypanosoma cruzi, unspecified product

Source Database / ID:  TriTrypDB  GeneDB

pI: 9.4131 | Length (AA): 133 | MW (Da): 15403 | Paralog Number: 2

Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0

Pfam domains

PF09149   Domain of unknown function (DUF1935)

Gene Ontology

Mouse over links to read term descriptions.
No GO information for this protein.

Metabolic Pathways

This gene is not mapped to any metabolic pathway in KEGG.

Structural information

Modbase 3D models:

There are 2 models calculated for this protein. More info on these models, including the models themselves is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
1 128 2fe0 (A) 1 130 62.00 0 1 1.71601 -0.62
11 125 1r75 (A) 12 132 38.00 0 1 1.37626 -0.89

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

No structure availble in the PDB for this protein

Expression

Upregulation Percent Ranking Stage Dataset
Upper 80-100% percentile epimastigote, metacyclic. Smircich P
Show/Hide expression data references
  • Smircich P Ribosome profiling reveals translation control as a key mechanism generating differential gene expression in Trypanosoma cruzi.

Orthologs

Ortholog group members (OG5_138266)

Species Accession Gene Product
Leishmania braziliensis LbrM.20.5530   calpain-like cysteine peptidase, putative,calpain-like cysteine peptidase, Clan CA, family C2
Leishmania donovani LdBPK_201350.1   small myristoylated protein 1
Leishmania infantum LinJ.20.1350   small myristoylated protein-1, putative;with=GeneDB:LmjF20.1310;with=GeneDB:LmjF20.1310
Leishmania major LmjF.20.1310   small myristoylated protein-1
Leishmania mexicana LmxM.20.1310   calpain-like cysteine peptidase, putative,calpain-like cysteine peptidase, Clan CA, family C2
Trypanosoma brucei Tb927.1.2230   small myristoylated protein 1-1
Trypanosoma brucei Tb927.1.2260   small myristoylated protein 1-2
Trypanosoma congolense TcIL3000_1_1260   small myristoylated protein 1-1
Trypanosoma congolense TcIL3000_1_1270   small myristoylated protein 1-2
Trypanosoma cruzi TcCLB.509003.30   small myristoylated protein 1-1
Trypanosoma cruzi TcCLB.509003.40   small myristoylated protein 1-2
Trypanosoma cruzi TcCLB.506563.70 this record   unspecified product

Essentiality

TcCLB.506563.70 has one or more orthologs with essentiality data
Gene/Ortholog Organism Phenotype Source Study
Tb927.1.2260 Trypanosoma brucei significant loss of fitness in bloodstream forms (3 days) alsford
Tb927.1.2260 Trypanosoma brucei significant loss of fitness in bloodstream forms (6 days) alsford
Tb927.1.2260 Trypanosoma brucei significant loss of fitness in procyclic forms alsford
Tb927.1.2260 Trypanosoma brucei significant loss of fitness in differentiation of procyclic to bloodstream forms alsford
Tb927.1.2230 Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (3 days) alsford
Tb927.1.2230 Trypanosoma brucei significant gain of fitness in bloodstream forms (6 days) alsford
Tb927.1.2230 Trypanosoma brucei significant gain of fitness in procyclic forms alsford
Tb927.1.2230 Trypanosoma brucei no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms alsford
Show/Hide essentiality data references
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Species Known druggable target Linked compounds Reference
Leishmania major small myristoylated protein-1 Compounds References
By sequence similarity to non orthologous druggable targets
Species Target Length Identity Alignment span Linked Drugs Reference
Leishmania major small myristoylated protein-3, putative 115 aa 49.5% 111 aa Compounds References

Obtained from network model

Ranking Plot


Putative Drugs List


Compound Raw Global Species
0.0419 0.4897 0.4897
0.0499 0.4933 0.4931
0.0404 0.4584 0.4964

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier TcCLB.506563.70 (Trypanosoma cruzi), unspecified product
Title for this comment
Comment